Empatica Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
Empatica is a MIT spin-off in the biotechnology research sector that focuses on digital health. The company is based in Boston, Massachusetts, and maintains offices in Milan and Seoul. It develops, manufactures, and deploys medical-grade wearables and digital biomarkers, supported by an AI-driven platform designed for continuous health monitoring and early detection of medical conditions. The Health Monitoring Platform—the FDA-cleared system—comprises EmbracePlus and EmbraceMini wearables and a broad library of validated digital measures that enables institutional partners to remotely collect patient data for trials and studies on sleep, stress, epilepsy, and more. Empatica has focused on epilepsy monitoring, with the Embrace wearable achieving FDA clearance for seizure detection in neurology. In 2024, the firm expanded its epilepsy monitoring capabilities with EpiMonitor, a combined wrist-worn device and smartphone app. In 2025, it launched EmbraceMini, touted as the world's smallest wrist-worn actigraphy device, aimed at improving comfort and data quality in clinical trials.